Published in J Clin Invest on September 01, 2003
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut (2006) 2.24
Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J Clin Invest (2006) 1.66
Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. J Clin Invest (2005) 1.61
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol (2006) 1.59
Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade. J Immunol (2009) 1.37
Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin Exp Immunol (2009) 1.04
Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol (2011) 1.01
Innate signaling networks in mucosal IgA class switching. Adv Immunol (2010) 0.97
Rapid dendritic cell mobilization to the large intestinal epithelium is associated with resistance to Trichuris muris infection. J Immunol (2009) 0.91
The role of the lactadherin in promoting intestinal DCs development in vivo and vitro. Clin Dev Immunol (2010) 0.83
Role of secretory IgA in the mucosal sensing of commensal bacteria. Gut Microbes (2014) 0.80
The intraperitoneal inoculation of Lactobacillus casei in mice induces total protection against Trichinella spiralis infection at low challenge doses. Parasitol Res (2011) 0.78
Morphology and ontogeny of dendritic cells in rats at different development periods. World J Gastroenterol (2009) 0.77
EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance. Nat Commun (2016) 0.76
The Role of Mannan-Binding Lectin (MBL) Gene Polymorphism in Ulcerative Colitis. J Clin Biochem Nutr (2008) 0.76
Probiotics for photoprotection. Dermatoendocrinol (2009) 0.76
Thymic Stromal Lymphopoietin: To Cut a Long Story Short. Cell Mol Gastroenterol Hepatol (2017) 0.75
Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain. Infect Immun (2014) 0.75
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 22.89
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Commensal host-bacterial relationships in the gut. Science (2001) 14.82
Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol (2001) 11.07
Gut flora in health and disease. Lancet (2003) 9.85
Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem (2003) 9.37
The immunology of mucosal models of inflammation. Annu Rev Immunol (2001) 9.08
Mucosal flora in inflammatory bowel disease. Gastroenterology (2002) 8.42
A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science (2000) 5.78
Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol (2003) 5.05
Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest (2003) 3.73
Crohn's disease. Lancet (2002) 3.53
Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med (1996) 1.59
Timing, localization, and persistence of colonization by segmented filamentous bacteria in the neonatal mouse gut depend on immune status of mothers and pups. Infect Immun (2001) 1.56
Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology (1999) 1.47
The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl (2001) 1.43
How the gut senses its content. Cell Microbiol (2002) 1.12
Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity. Crit Rev Immunol (2002) 1.05
Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches. J Immunol (2003) 0.98
Regional variation of the alphabeta T cell repertoire in the colon of healthy individuals and patients with Crohn's disease. Hum Immunol (2002) 0.81
A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med (2007) 15.17
Innate lymphoid cells--a proposal for uniform nomenclature. Nat Rev Immunol (2013) 7.94
Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med (2006) 7.76
Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature (2010) 6.44
Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature (2011) 6.43
CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med (2003) 6.00
Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol (2003) 5.94
IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med (2006) 5.76
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol (2005) 5.43
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity (2006) 5.40
Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med (2005) 4.47
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev (2006) 4.40
T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med (2005) 4.28
Dendritic cells in intestinal immune regulation. Nat Rev Immunol (2008) 4.20
Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol (2006) 4.04
Regulatory T cells and intestinal homeostasis. Immunol Rev (2005) 3.82
Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol (2009) 3.80
Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med (2008) 3.74
Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity (2010) 3.52
Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity (2010) 3.51
Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol (2006) 3.42
Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity (2008) 3.40
Regulatory T cells reinforce intestinal homeostasis. Immunity (2009) 3.27
E-cadherin marks a subset of inflammatory dendritic cells that promote T cell-mediated colitis. Immunity (2010) 2.78
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med (2011) 2.74
Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity (2012) 2.72
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med (2013) 2.50
Emerging challenges in regulatory T cell function and biology. Science (2007) 2.11
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med (2012) 2.11
Colitogenic Th1 cells are present in the antigen-experienced T cell pool in normal mice: control by CD4+ regulatory T cells and IL-10. J Immunol (2003) 2.08
The interleukin-23 axis in intestinal inflammation. Immunol Rev (2008) 2.06
Pathogenic and protective roles of MyD88 in leukocytes and epithelial cells in mouse models of inflammatory bowel disease. Gastroenterology (2010) 2.01
Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol (2002) 1.88
Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. Blood (2011) 1.83
Depletion of CD25+ regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun (2002) 1.80
Segmented filamentous bacteria in a defined bacterial cocktail induce intestinal inflammation in SCID mice reconstituted with CD45RBhigh CD4+ T cells. Inflamm Bowel Dis (2007) 1.73
Microbiota, disease, and back to health: a metastable journey. Sci Transl Med (2012) 1.70
OX40 is required for regulatory T cell-mediated control of colitis. J Exp Med (2010) 1.62
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. Blood (2012) 1.60
Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann N Y Acad Sci (2005) 1.59
The IL23 axis plays a key role in the pathogenesis of IBD. Gut (2007) 1.58
A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3. Blood (2014) 1.58
TLR2-independent induction and regulation of chronic intestinal inflammation. Eur J Immunol (2010) 1.55
Regulatory T cells. Curr Opin Pharmacol (2004) 1.52
Intestinal inflammation abrogates the tolerogenic properties of MLN CD103+ dendritic cells. Eur J Immunol (2010) 1.47
An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med (2010) 1.42
Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat Immunol (2005) 1.30
Cure of innate intestinal immune pathology by CD4+CD25+ regulatory T cells. Immunol Lett (2005) 1.20
CD4(+) T-cell subsets in intestinal inflammation. Immunol Rev (2013) 1.17
Special regulatory T-cell review: Regulatory T cells and the intestinal tract--patrolling the frontier. Immunology (2008) 1.12
Lymphoid microenvironments and innate lymphoid cells in the gut. Trends Immunol (2012) 1.08
Re-establishing immunological self-tolerance in autoimmune disease. Nat Med (2012) 1.06
Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease. Eur J Immunol (2009) 1.04
Interleukin-10 in the regulation of T cell-induced colitis. J Autoimmun (2003) 0.99
CTLA-4 expression on antigen-specific cells but not IL-10 secretion is required for oral tolerance. Eur J Immunol (2002) 0.98
Homeostasis of intestinal immune regulation. Microbes Infect (2002) 0.96
Immunology: Dendritic-cell genealogy. Nature (2009) 0.96
Hybrid Treg cells: steel frames and plastic exteriors. Nat Immunol (2009) 0.92
Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development. J Immunol (2007) 0.89
The role of mucosal T lymphocytes in regulating intestinal inflammation. Springer Semin Immunopathol (2005) 0.85
Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2. J Immunol (2013) 0.85
Immunology. The gut's Clostridium cocktail. Science (2011) 0.84
Gpr83 expression is not required for the maintenance of intestinal immune homeostasis and regulation of T-cell-dependent colitis. Immunology (2008) 0.84
Prenatal tolerance--a role for regulatory T cells? Eur J Immunol (2005) 0.82
Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A. Vaccine (2012) 0.81
Immunology. Feed your Tregs more fiber. Science (2013) 0.80
Regulatory mechanisms in graft-versus-host responses. Biol Blood Marrow Transplant (2009) 0.77
Homing of intestinal immune cells. Novartis Found Symp (2004) 0.76
Immunology: Malnutrition promotes rogue bacteria. Nature (2012) 0.76
Fiona Powrie: Gut diplomacy. Interview by Amy Maxmen. J Exp Med (2010) 0.75
Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat Med (2017) 0.75
Gender equality: is it real? Eur J Immunol (2012) 0.75